Browsing: DFS

Adjuvant ensartinib (Ensacove) significantly improved disease-free survival (DFS) vs placebo in patients with completely resected, ALK-positive stage IB to IIIB…

Administering nivolumab (Opdivo) after standard-of-care adjuvant therapy did not improve disease-free survival (DFS) compared with best supportive care among patients…

Three years of adjuvant low-dose aspirin did not significantly improve disease-free survival (DFS) over placebo in patients with stage III…

Shared at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, updated results from the phase 3 lidERA Breast…

The primary end point of diease-free survival (DFS) was not met in the phase 3 RAMPART (NCT03288532) trial, which assessed…

Surgery after 6 cycles of neoadjuvant chemotherapy (NACT) did not improve outcomes nor meet the primary end point of disease-free…

Atezolizumab (Tecentriq) plus mFOLFOX6 (fluorouracil, oxaliplatin, leucovorin) significantly improved disease-free survival (DFS) compared with mFOLFOX6 alone in patients with stage…

The addition of belzutifan (Welireg) to adjuvant pembrolizumab (Keytruda) significantly improved disease-free survival (DFS) for patients with clear cell renal…